Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17931863rdf:typepubmed:Citationlld:pubmed
pubmed-article:17931863lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:17931863lifeskim:mentionsumls-concept:C0028049lld:lifeskim
pubmed-article:17931863lifeskim:mentionsumls-concept:C0600423lld:lifeskim
pubmed-article:17931863lifeskim:mentionsumls-concept:C1333902lld:lifeskim
pubmed-article:17931863lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:17931863pubmed:issue23lld:pubmed
pubmed-article:17931863pubmed:dateCreated2007-11-6lld:pubmed
pubmed-article:17931863pubmed:abstractTextA series of 3-nitro-4-substituted-aminobenzoic acids were prepared and found to act as potent and highly selective agonists of the orphan human GPCR GPR109b, a low affinity receptor for niacin. No activity was observed at the closely homologous high affinity niacin receptor, GPR109a. A second series, comprising 6-amino-substituted nicotinic acids was, also prepared and several analogues showed comparable activity to the nitroaryl series.lld:pubmed
pubmed-article:17931863pubmed:languageenglld:pubmed
pubmed-article:17931863pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:citationSubsetIMlld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931863pubmed:statusMEDLINElld:pubmed
pubmed-article:17931863pubmed:monthDeclld:pubmed
pubmed-article:17931863pubmed:issn1464-3405lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:SempleGraemeGlld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:ConnollyDanie...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:TamuraSusan...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:WebbPeter JPJlld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:RichmanJeremy...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:ChenRuopingRlld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:SkinnerPhilip...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:CherrierMarti...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:SageCarleton...lld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:DangHuong THTlld:pubmed
pubmed-article:17931863pubmed:authorpubmed-author:PrideCameron...lld:pubmed
pubmed-article:17931863pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17931863pubmed:day1lld:pubmed
pubmed-article:17931863pubmed:volume17lld:pubmed
pubmed-article:17931863pubmed:ownerNLMlld:pubmed
pubmed-article:17931863pubmed:authorsCompleteYlld:pubmed
pubmed-article:17931863pubmed:pagination6619-22lld:pubmed
pubmed-article:17931863pubmed:dateRevised2011-11-3lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:meshHeadingpubmed-meshheading:17931863...lld:pubmed
pubmed-article:17931863pubmed:year2007lld:pubmed
pubmed-article:17931863pubmed:articleTitle3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.lld:pubmed
pubmed-article:17931863pubmed:affiliationMedicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA. pskinner@arenapharm.comlld:pubmed
pubmed-article:17931863pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17931863pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17931863lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17931863lld:pubmed